BLCM Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2022-04-29 | 2021 | Richard A. Fair, President and Chief Executive Officer | 600,686 | 0 | 0 | 293,924 | 20,673 | 1,467,174 |
| 2022-04-29 | 2020 | Richard A. Fair, President and Chief Executive Officer | 625,910 | 0 | 0 | 249,190 | 21,433 | 2,682,945 |
| 2022-04-29 | 2021 | Charity D. Scripture, MS, PharmD, Chief Development Officer | 157,633 | 0 | 0 | 67,575 | 1,020 | 513,992 |
| 2021-04-30 | 2020 | Richard A. Fair, President and Chief Executive Officer | 625,910 | 0 | 0 | 249,190 | 21,433 | 2,682,945 |
| 2021-04-30 | 2019 | Richard A. Fair, President and Chief Executive Officer | 566,204 | 0 | 0 | 127,990 | 17,690 | 1,732,888 |
| 2021-04-30 | 2020 | Atabak Mokari , Former Chief Financial Officer | 408,373 | 0 | 163,764 | 0 | 536,708 | 1,651,734 |
| 2021-04-30 | 2019 | Atabak Mokari , Former Chief Financial Officer | 375,000 | 0 | 0 | 61,500 | 2,233 | 1,107,901 |
| 2021-04-30 | 2020 | Shane M. Ward , Former Chief Legal and Strategy Officer and Corporate Secretary | 407,752 | 0 | 164,114 | 0 | 552,275 | 1,536,334 |
| 2021-04-30 | 2019 | Shane M. Ward , Former Chief Legal and Strategy Officer and Corporate Secretary | 374,062 | 0 | 0 | 61,705 | 17,941 | 606,859 |
| 2020-04-27 | 2018 | Richard A. Fair, President and Chief Executive Officer | 551,050 | 0 | 0 | 280,347 | 17,527 | 3,278,125 |
| 2020-04-27 | 2018 | Shane M. Ward, Chief Legal and Strategy Officer and Corporate Secretary | 208,205 | 0 | 79,500 | 82,365 | 8,067 | 1,004,867 |
| 2020-04-27 | 2019 | Shane M. Ward, Chief Legal and Strategy Officer and Corporate Secretary | 374,062 | 0 | 0 | 61,705 | 17,941 | 606,859 |
| 2020-04-27 | 2018 | Alan K. Smith, Ph.D., Executive Vice President, Technology Operations | 381,100 | 0 | 86,531 | 141,007 | 57,348 | 967,838 |
| 2020-04-27 | 2019 | Alan K. Smith, Ph.D., Executive Vice President, Technology Operations | 388,087 | 0 | 0 | 63,750 | 84,590 | 791,678 |
| 2020-04-27 | 2019 | Richard A. Fair, President and Chief Executive Officer | 566,204 | 0 | 0 | 127,990 | 17,690 | 1,732,888 |
| 2019-04-25 | 2017 | Alan A. Musso, C.P.A., C.M.A., former Chief Financial Officer and Treasurer | 385,000 | 0 | 104,175 | 78,829 | 47,919 | 975,969 |
| 2019-04-25 | 2018 | Richard A. Fair, President and Chief Executive Officer | 551,050 | 0 | 0 | 280,347 | 17,527 | 3,278,125 |
| 2019-04-25 | 2017 | Richard A. Fair, President and Chief Executive Officer | 494,532 | 0 | 0 | 534,731 | 13,791 | 4,882,462 |
| 2019-04-25 | 2018 | Shane M. Ward, General Counsel and Secretary | 208,205 | 0 | 79,500 | 82,365 | 8,067 | 1,004,867 |
| 2019-04-25 | 2018 | William Grossman, M.D. Ph.D., former Chief Medical Officer | 372,942 | 0 | 168,300 | 377,182 | 14,842 | 1,568,125 |
| 2019-04-25 | 2018 | Alan A. Musso, C.P.A., C.M.A., former Chief Financial Officer and Treasurer | 290,127 | 0 | 115,375 | 0 | 264,885 | 1,072,856 |
| 2018-04-26 | 2017 | Richard A. Fair, President and Chief Executive Office | 494,532 | 0 | 0 | 534,731 | 13,791 | 4,882,462 |
| 2018-04-26 | 2017 | Thomas J. Farrell, former President and Chief Executive Officer | 45,822 | 0 | 373,293 | 0 | 865,968 | 1,718,330 |
| 2018-04-26 | 2017 | Alan A. Musso, C.P.A., C.M.A., Chief Financial Officer and Treasurer | 385,000 | 0 | 104,175 | 78,829 | 47,919 | 975,969 |
| 2018-04-26 | 2017 | Alan K. Smith, Ph.D., Executive Vice President, Technology Operations | 357,773 | 0 | 86,813 | 83,719 | 59,494 | 1,045,295 |
| 2017-04-26 | 2015 | Alan A. Musso, C.P.A., C.M.A., Chief Financial Officer and Treasurer | 347,500 | 0 | 0 | 97,300 | 32,186 | 1,535,494 |
| 2017-04-26 | 2016 | Thomas J. Farrell, former President and Chief Executive Officer | 501,100 | 0 | 0 | 177,891 | 2,196 | 2,649,129 |
| 2017-04-26 | 2015 | Thomas J. Farrell, former President and Chief Executive Officer | 474,583 | 0 | 0 | 189,834 | 2,198 | 3,489,303 |
| 2017-04-26 | 2016 | Annemarie Moseley, Ph.D., M.D., Chief Operating Officer and Executive Vice President of Clinical Development | 422,300 | 0 | 0 | 119,934 | 7,772 | 2,087,461 |
| 2017-04-26 | 2015 | Annemarie Moseley, Ph.D., M.D., Chief Operating Officer and Executive Vice President of Clinical Development | 410,000 | 0 | 0 | 131,200 | 13,232 | 2,395,422 |
| 2017-04-26 | 2016 | Alan A. Musso, C.P.A., C.M.A., Chief Financial Officer and Treasurer | 368,000 | 0 | 0 | 91,448 | 29,520 | 1,226,946 |
| 2016-04-27 | 2014 | Thomas J. Farrell, President and Chief Executive Officer | 373,666 | 0 | 0 | 131,244 | 7,257 | 3,706,094 |
| 2016-04-27 | 2015 | Alan A. Musso, C.P.A., C.M.A., Chief Financial Officer and Treasurer | 347,500 | 0 | 0 | 97,300 | 32,186 | 1,535,494 |
| 2016-04-27 | 2014 | Annemarie Moseley, Ph.D., M.D., Chief Operating Officer and Executive Vice President of Clinical Development | 367,093 | 0 | 0 | 104,496 | 14,541 | 1,963,315 |
| 2016-04-27 | 2015 | Annemarie Moseley, Ph.D., M.D., Chief Operating Officer and Executive Vice President of Clinical Development | 410,000 | 0 | 0 | 131,200 | 13,232 | 2,395,422 |
| 2016-04-27 | 2015 | Thomas J. Farrell, President and Chief Executive Officer | 474,583 | 0 | 0 | 189,834 | 2,198 | 3,489,303 |
| 2015-04-21 | 2014 | Thomas J. Farrell, President and Chief Executive Officer | 373,666 | 0 | 0 | 131,244 | 7,257 | 3,706,094 |
| 2015-04-21 | 2014 | Annemarie Moseley, Ph.D., M.D., Chief Operating Officer and Executive Vice President of Clinical Development | 367,093 | 0 | 0 | 104,496 | 14,541 | 1,963,315 |
| 2015-04-21 | 2013 | Annemarie Moseley, Ph.D., M.D., Chief Operating Officer and Executive Vice President of Clinical Development | 320,000 | 0 | 0 | 76,800 | 11,429 | 501,229 |
| 2015-04-21 | 2014 | Kevin M. Slawin, M.D., Chief Technology Officer | 259,167 | 0 | 0 | 81,638 | 2,340 | 1,820,330 |
| 2015-04-21 | 2013 | Kevin M. Slawin, M.D., Chief Technology Officer | 250,000 | 0 | 0 | 60,000 | 2,100 | 858,100 |
| 2015-04-21 | 2013 | Thomas J. Farrell, President and Chief Executive Officer | 350,000 | 0 | 0 | 84,000 | 4,006 | 438,006 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
